MCL1 and chronic myelogenous leukemia, BCR-ABL1 positive: This study evaluated the synergistic effect of EE-84, a cytostatic marine compound, with the Mcl-1 inhibitor A-1210477 against CML K562 and K562 imatinib-resistant cells.